Uveitis reactivation following recombinant zoster vaccination.

Laura Kopplin // Publications // Jul 30 2021

PubMed ID: 34041415

Author(s): Richards PJ, Wingelaar MJ, Armbrust KR, Kopplin LJ. Uveitis reactivation following recombinant zoster vaccination. Am J Ophthalmol Case Rep. 2021 May 3;23:101115. doi: 10.1016/j.ajoc.2021.101115. eCollection 2021 Sep. PMID 34041415

Journal: American Journal Of Ophthalmology Case Reports, Volume 23, Sep 2021

Purpose Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV).

Observations One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV, requiring treatment with systemic corticosteroids. Two patients with previously controlled anterior uveitis developed new anterior segment inflammation after RZV; both were treated with topical corticosteroids and systemic antiviral therapy.

Conclusion and importance Uveitis recurrence is an infrequent but serious potential ocular side effect of recombinant zoster vaccination.

© 2021 The Authors. Published by Elsevier Inc.